Summary
231.61 5.62(2.49%)05/10/2024
Steris Plc (STE)
Steris Plc (STE)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 1.68 | 4.15 | 0.19 | -5.73 | -2.37 | 12.74 | 67.76 | 13,686.08 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 213.05 | |
| Open | 210.44 | |
| High | 213.54 | |
| Low | 209.36 | |
| Volume | 628,382 | |
| Change | 3.53 | |
| Change % | 1.68 | |
| Avg Volume (20 Days) | 462,961 | |
| Volume/Avg Volume (20 Days) Ratio | 1.36 | |
| 52 Week Range | 185.22 - 254.00 | |
| Price vs 52 Week High | -16.12% | |
| Price vs 52 Week Low | 15.02% | |
| Range | 1.24 | |
| Gap Up/Down | 0.85 | |
Fundamentals | ||
| Market Capitalization (Mln) | 22,859 | |
| EBIDTA | 1,422,059,008 | |
| PE Ratio | 36.5237 | |
| PEG Ratio | 6.8839 | |
| WallStreet Target Price | 239.86 | |
| Book Value | 64.9280 | |
| Earnings Per Share | 5.6900 | |
| EPS Estimate Current Quarter | 2.1700 | |
| EPS Estimate Next Quarter | 2.4700 | |
| EPS Estimate Current Year | 8.6300 | |
| EPS Estimate Next Year | 9.3800 | |
| Diluted EPS (TTM) | 5.6900 | |
| Revenues | ||
| Profit Marging | 0.1048 | |
| Operating Marging (TTM) | 0.1590 | |
| Return on asset (TTM) | 0.0477 | |
| Return on equity (TTM) | 0.0911 | |
| Revenue TTM | 5,407,384,064 | |
| Revenue per share TTM | 54.7090 | |
| Quarterly Revenue Growth (YOY) | 0.1480 | |
| Quarterly Earnings Growth (YOY) | 0.1450 | |
| Gross Profit (TTM) | 2,159,692,000 | |
| Dividends | ||
| Dividend Share | 1.9800 | |
| Dividend Yield | 0.0100 | |
| Valuations | ||
| Trailing PE | 36.5237 | |
| Forward PE | 23.2558 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 3.1421 | |
| Revenue Enterprise Value | 4.3406 | |
| EBITDA Enterprise Value | 16.8373 | |
| Shares | ||
| Shares Outstanding | 98,814,000 | |
| Shares Float | 98,444,471 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.03 | |
| Insider (%) | 0.27 | |
| Institutions (%) | 97.74 | |
05/09 14:30 EST - Seeking Alpha
STERIS plc (STE) Q4 2024 Earnings Call Transcript
STERIS plc (NYSE:STE ) Q4 2024 Earnings Conference Call May 9, 2024 9:00 AM ET Company Participants Julie Winter - VP, IR Mike Tokich - SVP and CFO Dan Carestio - President and CEO Conference Call Participants Patrick Wood - Morgan Stanley Brett Fishbin - KeyBanc Mike Matson - Needham & Company Jason Bednar - Piper Sandler Operator Good day, and welcome to the STERIS plc Fourth Quarter 2024 Conference Call. All participants will be in a listen-only mode.
STERIS plc (STE) Q4 2024 Earnings Call Transcript
STERIS plc (NYSE:STE ) Q4 2024 Earnings Conference Call May 9, 2024 9:00 AM ET Company Participants Julie Winter - VP, IR Mike Tokich - SVP and CFO Dan Carestio - President and CEO Conference Call Participants Patrick Wood - Morgan Stanley Brett Fishbin - KeyBanc Mike Matson - Needham & Company Jason Bednar - Piper Sandler Operator Good day, and welcome to the STERIS plc Fourth Quarter 2024 Conference Call. All participants will be in a listen-only mode.
05/09 13:31 EST - Zacks Investment Research
STERIS (STE) Q4 Earnings Match Estimates, Margins Contract
STERIS' (STE) fourth-quarter performance in AST is dented by a decline in capital equipment revenues. The contraction of margins is concerning.
STERIS (STE) Q4 Earnings Match Estimates, Margins Contract
STERIS' (STE) fourth-quarter performance in AST is dented by a decline in capital equipment revenues. The contraction of margins is concerning.
05/08 19:01 EST - Zacks Investment Research
Steris (STE) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Steris (STE) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Steris (STE) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Steris (STE) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
05/08 18:46 EST - Zacks Investment Research
Steris (STE) Matches Q4 Earnings Estimates
Steris (STE) came out with quarterly earnings of $2.41 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $2.30 per share a year ago.
Steris (STE) Matches Q4 Earnings Estimates
Steris (STE) came out with quarterly earnings of $2.41 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $2.30 per share a year ago.
05/03 10:21 EST - Zacks Investment Research
Exploring Analyst Estimates for Steris (STE) Q4 Earnings, Beyond Revenue and EPS
Get a deeper insight into the potential performance of Steris (STE) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Exploring Analyst Estimates for Steris (STE) Q4 Earnings, Beyond Revenue and EPS
Get a deeper insight into the potential performance of Steris (STE) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
05/02 10:01 EST - Zacks Investment Research
Here's Why You Should Retain STERIS (STE) Stock for Now
STERIS' (STE) strong prospects in the healthcare and pharmaceutical industries bode well for investors.
Here's Why You Should Retain STERIS (STE) Stock for Now
STERIS' (STE) strong prospects in the healthcare and pharmaceutical industries bode well for investors.
04/24 16:30 EST - GlobeNewsWire
STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024
DUBLIN, IRELAND, April 24, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 fourth quarter and full year financial results at 9:00 a.m. ET on May 9, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.
STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024
DUBLIN, IRELAND, April 24, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 fourth quarter and full year financial results at 9:00 a.m. ET on May 9, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.
04/22 15:16 EST - Zacks Investment Research
Should You Buy STERIS (STE) Stock Ahead of Q4 Earnings?
STERIS (STE) is expected to have witnessed the normalization of the Healthcare backlog, as the company is currently able to ship at a faster pace than the receipt of new orders.
Should You Buy STERIS (STE) Stock Ahead of Q4 Earnings?
STERIS (STE) is expected to have witnessed the normalization of the Healthcare backlog, as the company is currently able to ship at a faster pace than the receipt of new orders.
04/15 12:21 EST - Zacks Investment Research
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
The Zacks Medical - Instruments industry is expected to gain from the rising adoption of smart healthcare options, including genAI. However, supply issues and staffing shortages continue to disrupt growth.
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
The Zacks Medical - Instruments industry is expected to gain from the rising adoption of smart healthcare options, including genAI. However, supply issues and staffing shortages continue to disrupt growth.
04/09 10:36 EST - Zacks Investment Research
Here's Why Steris (STE) is Poised for a Turnaround After Losing -9.06% in 4 Weeks
The heavy selling pressure might have exhausted for Steris (STE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Here's Why Steris (STE) is Poised for a Turnaround After Losing -9.06% in 4 Weeks
The heavy selling pressure might have exhausted for Steris (STE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
03/28 12:20 EST - Zacks Investment Research
Here's Why Investors Should Retain STERIS (STE) Stock for Now
Investors are optimistic about STERIS (STE) on strong Healthcare business performance and raised 2024 guidance.
Here's Why Investors Should Retain STERIS (STE) Stock for Now
Investors are optimistic about STERIS (STE) on strong Healthcare business performance and raised 2024 guidance.
02/15 10:51 EST - Zacks Investment Research
Why Steris (STE) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Steris (STE) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
02/12 10:46 EST - Zacks Investment Research
Why Steris (STE) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Steris (STE) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
02/08 08:36 EST - Zacks Investment Research
STERIS (STE) Q3 Earnings Top Estimates, Fiscal '24 Sales View Up
STERIS' (STE) fiscal 2024 third-quarter results demonstrate the remarkable performance of the Healthcare segment.
STERIS (STE) Q3 Earnings Top Estimates, Fiscal '24 Sales View Up
STERIS' (STE) fiscal 2024 third-quarter results demonstrate the remarkable performance of the Healthcare segment.
02/07 19:31 EST - Zacks Investment Research
Compared to Estimates, Steris (STE) Q3 Earnings: A Look at Key Metrics
The headline numbers for Steris (STE) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, Steris (STE) Q3 Earnings: A Look at Key Metrics
The headline numbers for Steris (STE) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
02/07 18:46 EST - Zacks Investment Research
Steris (STE) Q3 Earnings and Revenues Top Estimates
Steris (STE) came out with quarterly earnings of $2.22 per share, beating the Zacks Consensus Estimate of $2.17 per share. This compares to earnings of $2.02 per share a year ago.
Steris (STE) Q3 Earnings and Revenues Top Estimates
Steris (STE) came out with quarterly earnings of $2.22 per share, beating the Zacks Consensus Estimate of $2.17 per share. This compares to earnings of $2.02 per share a year ago.
02/02 10:21 EST - Zacks Investment Research
Countdown to Steris (STE) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Get a deeper insight into the potential performance of Steris (STE) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Countdown to Steris (STE) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Get a deeper insight into the potential performance of Steris (STE) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
01/31 11:05 EST - Zacks Investment Research
Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
01/23 16:30 EST - GlobeNewsWire
STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024
DUBLIN, IRELAND, Jan. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 third quarter financial results at 9:00 a.m. ET on February 8, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.
STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024
DUBLIN, IRELAND, Jan. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 third quarter financial results at 9:00 a.m. ET on February 8, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.